• Latest Posts
Podcast 14 Apr 2023

Beyond Biotech podcast 41: Sarcoidosis

10 immunotherapy companies making waves in 2023

Orphan drug designation for Laevoroc metabolic immune checkpoint inhibitor

Positive topline data from sepsis trial

Certa scleroderma study shows improvement in more than 60% of patients

FDA clearance for ‘revolutionary’ approach to J-Pouch issue


Lupus treatment hope from Japanese miRNA research

CytoReason expands deal with Sanofi to look at IBD

Anticancer drugs could lead to new sepsis treatment

Positive Dupixent eosinophilic esophagitis phase 3 results

Apogee Therapeutics raises $169M to tackle immunological and inflammatory disorders

Tetra announce significant results from the study of Onternabez combined with Favipiravir